Viking Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.914; its P/E ratio is -91.09; Viking Therapeutics is scheduled to report earnings on April 24, 2024, and the estimated EPS forecast is $-0.28. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -24.61M	$ -22.53M	$ -19.23M	$ -19.53M	$ -20.28M
EBITDA	$ -32.71M	-	$ -19.12M	$ -19.43M	$ -20.21M
Net Income Common Stockholders	$ -24.61M	$ -22.53M	$ -19.23M	$ -19.53M	$ -19.56M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 362.08M	$ 376.24M	$ 392.92M	$ 135.66M	$ 155.49M
Total Assets	$ 368.49M	$ 382.66M	$ 400.69M	$ 150.90M	$ 168.53M
Total Debt	$ 1.26M	$ 1.34M	$ 1.41M	$ 1.49M	$ 1.56M
Net Debt	$ -360.82M	$ -374.90M	$ -391.51M	$ -134.17M	$ -153.92M
Total Liabilities	$ 20.07M	$ 14.42M	$ 14.58M	$ 16.83M	$ 23.21M
Stockholders Equity	$ 348.42M	$ 368.24M	$ 386.12M	$ 134.06M	$ 145.32M
Cash Flow	-
Free Cash Flow	$ -17.64M	-	$ -11.44M	$ -24.64M	$ -10.93M
Operating Cash Flow	$ -17.64M	$ -19.66M	$ -11.44M	$ -24.64M	$ -10.93M
Investing Cash Flow	$ 35.73M	$ -12.53M	$ -204.48M	$ 2.20M	$ 7.26M
Financing Cash Flow	$ 188.00K	$ -74.00K	$ 267.08M	$ 4.18M	$ 10.75M

Currency in USD

Viking Therapeutics Earnings and Revenue History

Income Statement >

Viking Therapeutics Debt to Assets

Balance Sheet >

Viking Therapeutics Cash Flow

Cash Flow >

Viking Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing